1.8M
Microbial cells per cm²
on human skin
Microbiome-matched skincare

Build a routine
your skin actually needs

We sequence your skin's microbiome and match what we find to a complete, dermatologist-verified routine — new products or ones you already own.

Already have a test code?
Placeholder · Brand photography
Skin, closely observed
Full-bleed editorial image · 1440 × 650px recommended
Macro skin texture · neutral light · no product in frame
Replace with final brand photography before launch
4
Primary microbial
condition profiles
38+
Species identified
per sequencing panel
$199
Test kit + full
skin profile report
6mo
Recommended
retest interval
"Most routines are built on trial and error. Yours should be built on what's actually on your skin."
Method

From sample
to routine

01
Collect and ship
Sterile swab kit arrives in 3–5 days. Two minutes to collect, prepaid envelope to return.
02
16S rRNA sequencing
Species identified at genus and species level by relative abundance. Results in 10–14 days.
03
Read your biology
Raw composition first. Then reference ranges — so you see exactly how far from normal each reading sits.
04
Understand the mechanism
Before products: the ingredient classes the literature supports for your profile, and how each one works.
05
Build your routine
Products as conclusions. All reasoning made explicit. Nothing recommended that isn't earned by the biology.
Your results

Enter your report code

Your code appears in the confirmation email sent when your sample was received at the lab. It begins with SKN-.

No code yet?  Load demo report SKN-DEMO

The science

How we read your skin's microbial ecosystem

How we sequence your skin, what the data means, how products are selected, and what microbiome testing can and cannot currently tell you.

1.8M
Microbial cells per cm²
on human skin surface

We amplify and sequence the V3–V4 hypervariable regions of the 16S rRNA gene from your swab.1 Reads are matched against a curated reference database to identify species and calculate relative abundance — how much of the total community each one represents.

Relative abundance, not absolute count. A species at 38% is 38% of what the sequencer detected — not 38% of everything on your skin.

01
Swab collection. Sterile swab applied to forehead, cheek, and nasolabial fold. Sample stabilised immediately.
02
DNA extraction. Bead-beating protocol optimised for skin samples, which have lower microbial biomass than gut samples.2
03
PCR amplification. V3–V4 region amplified with validated primers. Illumina paired-end sequencing; ~50,000–100,000 reads per sample.
04
Bioinformatic analysis. DADA2 denoising generates ASVs,3 classified against the SILVA ribosomal RNA database.4
05
Report generation. Species abundances calculated, diversity indices computed, profile compared against reference ranges.
1 Klindworth A, et al. (2013). Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 41(1):e1.
2 Grice EA & Segre JA (2011). The skin microbiome. Nature Reviews Microbiology 9, 244–253.
3 Callahan BJ, et al. (2016). DADA2: High-resolution sample inference from Illumina amplicon data. Nature Methods 13, 581–583.
4 Quast C, et al. (2013). The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41(D1):D590–D596.

Ranges are derived from published skin microbiome literature — primarily Human Microbiome Project cohorts5 and studies from Grice et al. (2009)6 and Findley et al. (2013).7 We use the 10th–90th percentile across healthy adult populations as the reference band.

Population statistics, not clinical thresholds. Being outside the reference range describes where you sit relative to a distribution — it is not a clinical finding.

The barrier index is a composite score calculated from the species profile, weighting barrier-disrupting pathogens against commensal reference proportions. It is inferential, not a direct TEWL measurement.8

5 Human Microbiome Project Consortium (2012). Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214.
6 Grice EA, et al. (2009). Topographical and temporal diversity of the human skin microbiome. Science 324(5931):1190–1192.
7 Findley K, et al. (2013). Topographic diversity of fungal and bacterial communities in human skin. Nature 498, 367–370.
8 Nakatsuji T, et al. (2017). Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Science Translational Medicine 9(378).

Two-stage filter: does the product carry the ingredient class identified for this condition at an efficacious concentration?9 Does it avoid ingredients that would counteract the mechanism or disrupt the broader community?

Tier assignment reflects price and formulation refinement — not efficacy ranking. The same actives are present at every tier. Products are reviewed by a board-certified dermatologist before inclusion. Affiliate commission rates do not influence selection.

9 Zaenglein AL, et al. (2016). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology 74(5):945–973. Referenced for BHA, BPO, and retinoid evidence grades.

Microbiome science applied to skincare is a relatively recent field. We are transparent about where the evidence is strong and where it is preliminary.

Not a clinical finding
This is not a medical test and cannot diagnose skin conditions. Elevated C. acnes is associated with acne — it is not a diagnosis of acne. If you have active skin disease, consult a dermatologist.
Snapshot, not longitudinal
A single test reflects one point in time. The microbiome fluctuates with season, hormonal cycle, product use, and stress. The six-month retest is recommended to establish a trend, not a static profile.
16S has resolution limits
16S rRNA sequencing identifies species well but has limited strain-level resolution. Pathogenic and commensal strains of C. acnes are phylogenetically distinct but may not be differentiated by this method.10
Correlation, not causation
Elevated S. aureus correlates with barrier dysfunction — the direction of causality is bidirectional and context-dependent.11 We present correlations accurately and avoid overclaiming mechanistic certainty where the literature is equivocal.
10 Scholz CFP & Kilian M (2016). The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Cutibacterium gen. nov. Int J Syst Evol Microbiol. 66(11):4422–4432.
11 Kong HH, et al. (2012). Temporal shifts in the skin microbiome of atopic dermatitis patients correlate with disease flares. Genome Research 22(5):850–859.
Product catalog

All products, by condition

Browse the full recommendation set without entering a report code. Each product is listed with its condition rationale and the specific mechanism it addresses. Affiliate links are included and disclosed.

48
Products across
4 conditions × 3 tiers
Test kit

Understand what's actually living on your skin

A complete at-home swab kit, 16S rRNA sequencing, and a full five-step skin profile matched to your microbiome. Results in 10–14 days from sample receipt.

What's included
Swab kit
Sterile collection swabs, stabilisation buffer, prepaid return envelope
16S sequencing
V3–V4 amplicon sequencing, 50,000–100,000 reads, SILVA-classified
Skin profile report
Species composition, reference ranges, condition profile, five-step results flow
Product routine
Four-step routine in three price tiers, matched to your specific condition
Six-month retest
Retest recommended at six months to track longitudinal change (separate order)
Report access
Permanent access via your report code, no account required
$199
Test kit — one-time
You're on the list.
We'll notify you at the email address you provided when kits are available to ship. Expected first dispatch: Q2 2025.

Kits are not yet available to ship. Joining the waitlist reserves your place and locks in the $199 launch price. No payment taken until kits are ready to dispatch. Unsubscribe at any time.